跳至主要内容
临床试验/CTRI/2022/08/044952
CTRI/2022/08/044952尚未招募不适用

Noninvasive detection of Hemoglobin, bilirubin, oxygen saturation, creatinine and other basic healthcare parameter using EzeCheck device for across age groups.

Partha Pratim Das Mahapatra1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年1月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
300
试验地点
1
主要终点
Efficacy of the non-invasive device for determining the Hb levels.

研究概览

简要总结

We want to determine the efficacy of the newly developed non-invasive device to determine the Haemoglobin levels in the female patients after the delivery , to check how accurately the device can detect the cases of post-partum anemia.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • All female patients who have undergone delivery and prescribed for the Hemoglobin test.

排除标准

  • Applied Mehndi on finger tip or have any skin disease which can affect the upper dermal layer.

结局指标

主要结局

Efficacy of the non-invasive device for determining the Hb levels.

时间窗: 4 weeks

次要结局

  • Efficacy of the device in detecting post-partum anemia cases.(1 month)

研究者

发起方
Partha Pratim Das Mahapatra
申办方类型
Other [Med-tech Startup]

研究点 (1)

Loading locations...

相似试验

The efficacy of EzeCheck device for its use in the... | 临床试验